3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Completed
2
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
61
Stomach Neoplasms
10
HER2-positive Breast Cancer
7
Colorectal Neoplasms
6
Neoplasm Metastasis
5
Inflammatory Breast Neoplasms
3
Breast Diseases
3
Brain Neoplasms
3
Pathologic Complete Response
2
Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Cardiotoxicity
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Relapsed Pediatric Solid Tumor
1
Pancreatic Neoplasms
1
Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
1
Invasive Breast Cancer
1
Intestinal Neoplasms
1
HER2-positive Metastatic Breast Cancer
1
HER2-positive Gastric Cancer
1
HER2-positive
1
HER2+ Early or Locally Advanced Breast Cancer
1
HER2+ Breast Cancer
1
HER2 Positive Breast Cancer
1
HER-2 Positive Gastric Cancer
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Feasibility
1
Estrogen Receptor-positive Breast Cancer
1
Interventions
Cisplatin
22
Radiotherapy
15
Cetuximab
12
Docetaxel
11
Carboplatin
10
pembrolizumab
8
toripalimab
6
camrelizumab
6
Paclitaxel
5
Nivolumab
5
Neoadjuvant Therapy
5
Fluorouracil
5
Drug Therapy
5
Chemoradiotherapy
5
nimotuzumab
4
durvalumab
4
sintilimab
3
cemiplimab
3
apatinib
3
advexin
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Immunohistochemistry
3
Celecoxib
3
Blood Specimen Collection
3
nedaplatin
2
Therapeutics
2
Tegafur
2
Radiotherapy, Intensity-Modulated
2
Methotrexate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Squamous Cell Carcinoma of Head and Neck
×
Trastuzumab
×
Clear all
NCT06130007
2023-11-13
B2023-153
Sun Yat-sen University
Phase 2
Unknown
48 enrolled